The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
The global Gene Therapy market was valued at US$ 7077.6 million in 2023 and is anticipated to reach US$ 39700 million by 2030, witnessing a CAGR of 27.6% during the forecast period 2024-2030.
Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%.
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent.
In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy.
Report Scope
The Gene Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
- Biogen
- Novartis
- Gilead Sciences
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Amgen
- Spark Therapeutics
- Akcea Therapeutics
- bluebird bio
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
- Human Stem Cells Institute
Segment by Type
- Viral Gene Therapy
- Non-Viral Gene Therapy
Segment by Application
- Neurological Diseases
- Cancer
- Other
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Viral Gene Therapy
1.2.3 Non-Viral Gene Therapy
1.3 Market by Application
1.3.1 Global Gene Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy Market Perspective (2019-2030)
2.2 Gene Therapy Growth Trends by Region
2.2.1 Global Gene Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Therapy Historic Market Size by Region (2019-2024)
2.2.3 Gene Therapy Forecasted Market Size by Region (2025-2030)
2.3 Gene Therapy Market Dynamics
2.3.1 Gene Therapy Industry Trends
2.3.2 Gene Therapy Market Drivers
2.3.3 Gene Therapy Market Challenges
2.3.4 Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy Players by Revenue
3.1.1 Global Top Gene Therapy Players by Revenue (2019-2024)
3.1.2 Global Gene Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy Revenue
3.4 Global Gene Therapy Market Concentration Ratio
3.4.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2023
3.5 Gene Therapy Key Players Head office and Area Served
3.6 Key Players Gene Therapy Product Solution and Service
3.7 Date of Enter into Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy Breakdown Data by Type
4.1 Global Gene Therapy Historic Market Size by Type (2019-2024)
4.2 Global Gene Therapy Forecasted Market Size by Type (2025-2030)
5 Gene Therapy Breakdown Data by Application
5.1 Global Gene Therapy Historic Market Size by Application (2019-2024)
5.2 Global Gene Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Therapy Market Size (2019-2030)
6.2 North America Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Therapy Market Size by Country (2019-2024)
6.4 North America Gene Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapy Market Size (2019-2030)
7.2 Europe Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Therapy Market Size by Country (2019-2024)
7.4 Europe Gene Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy Market Size (2019-2030)
8.2 Asia-Pacific Gene Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapy Market Size (2019-2030)
9.2 Latin America Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Therapy Market Size by Country (2019-2024)
9.4 Latin America Gene Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy Market Size (2019-2030)
10.2 Middle East & Africa Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Therapy Introduction
11.1.4 Biogen Revenue in Gene Therapy Business (2019-2024)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Therapy Introduction
11.2.4 Novartis Revenue in Gene Therapy Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Detail
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene Therapy Introduction
11.3.4 Gilead Sciences Revenue in Gene Therapy Business (2019-2024)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Detail
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene Therapy Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene Therapy Business (2019-2024)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Detail
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene Therapy Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2019-2024)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene Therapy Introduction
11.6.4 Amgen Revenue in Gene Therapy Business (2019-2024)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Detail
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene Therapy Introduction
11.7.4 Spark Therapeutics Revenue in Gene Therapy Business (2019-2024)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Detail
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene Therapy Introduction
11.8.4 Akcea Therapeutics Revenue in Gene Therapy Business (2019-2024)
11.8.5 Akcea Therapeutics Recent Development
11.9 bluebird bio
11.9.1 bluebird bio Company Detail
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Gene Therapy Introduction
11.9.4 bluebird bio Revenue in Gene Therapy Business (2019-2024)
11.9.5 bluebird bio Recent Development
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Detail
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Gene Therapy Introduction
11.10.4 Sunway Biotech Revenue in Gene Therapy Business (2019-2024)
11.10.5 Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Detail
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Gene Therapy Introduction
11.11.4 SIBIONO Revenue in Gene Therapy Business (2019-2024)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Detail
11.12.2 AnGes Business Overview
11.12.3 AnGes Gene Therapy Introduction
11.12.4 AnGes Revenue in Gene Therapy Business (2019-2024)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Detail
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Gene Therapy Introduction
11.13.4 Orchard Therapeutics Revenue in Gene Therapy Business (2019-2024)
11.13.5 Orchard Therapeutics Recent Development
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Detail
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Gene Therapy Introduction
11.14.4 Human Stem Cells Institute Revenue in Gene Therapy Business (2019-2024)
11.14.5 Human Stem Cells Institute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
